Biotech

All Articles

Analysts explore Avidity's DMD win, exposing subtleties in data

.Avidity Biosciences pleased entrepreneurs along with phase 1/2 data in Duchenne muscular dystrophy ...

Actinogen's cortisol blocker falls short period 2 depression study

.Actinogen Medical's cortisol blocker has missed the key endpoint of a phase 2 research in anxiety, ...

Bivictrix decides going private only technique to take ADC into medical clinic

.Antibody-drug conjugates (ADCs) have gone to the facility of a lot of a billion-dollar biobuck lice...

TPG leadings up funds to $580M for expenditures across lifestyle scientific researches

.Resource supervisor TPG, which has actually assisted biotechs such as Sionna Rehabs and Santa Clam ...

Merck stops period 3 TIGIT test in bronchi cancer cells for futility

.Merck &amp Co.'s TIGIT plan has actually experienced yet another problem. Months after shuttering a...

After a difficult year, Exscientia folds up into Recursion

.After a year described through pipe hairstyles, the shift of its CEO and also cutbacks, Exscientia ...

Cullinan, after $25M bargain, restore bispecific to Port

.Cullinan Rehab was actually excited good enough along with Harbour BioMed's bispecific invulnerable...

A deeper consider Brutal Biotech's Ferocious 15

.Within this week's incident of "The Leading Pipe," our team're diving in to Ferocious Biotech's ann...

Lilly encounters phase 2 failure of tau-targeting med

.The confetti is still soaring from Eli Lilly's party celebrating the commendation of Alzheimer's ai...

Biogen CMO Maha Radhakrishnan joins Sofinnova-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our roundup of substantial management hirings, firings ...